Skip Navigation


Journal of Intellectual Property Law & Practice Advance Access originally published online on November 2, 2006
Journal of Intellectual Property Law & Practice 2006 1(13):818-819; doi:10.1093/jiplp/jpl186
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1/13/818    most recent
jpl186v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bisschop, K.
Right arrow Articles by van der Velden, R.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Authors (2006). Published by Oxford University Press. All rights reserved.

Current Intelligence

Lipitor battle in the Netherlands—District Court invalidates Warner-Lambert's EP '281 and holds EP '633 infringed

Klaas Bisschop and Ruud van der Velden
Lovells, Amsterdam

In the continuing Lipitor (atorvastatin) battle between the Indian company Ranbaxy and Pfizer/Warner-Lambert, the District Court of The Hague held that Ranbaxy's generic atorvastatin falls within the scope of protection of EP '633, the main patent covering atorvastatin, and invalidated another atorvastatin patent, EP '281.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.